Exelixis reported $53.26M in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Akebia Therapeutics AKBA:US $ -59.54M 23.49M
AstraZeneca AZN:LN 1954M 415M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Bristol Myers Squibb BMY:US $ 5289M 67M
Cytokinetics CYTK:US $ -76.09M 14.53M
Dicerna Pharmaceuticals DRNA:US $ -16.26M 24.01M
Eisai 4523:JP Y 5564M 50219M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Exelixis EXEL:US $ 53.26M 71.63M
Genmab GEN:DC DK 1171M 749M
Immunogen IMGN:US $ -37.34M 6.6M
IONIS PHARMACEUT IONS:US $ -84M 3M
Macrogenics MGNX:US $ -52.89M 12.95M
Mirati Therapeutics MRTX:US $ -76.76M 89.68M
Moderna Inc MRNA:US 3.55B 489M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Novartis NOVN:VX SF 4544M 120M
Puma Biotechnology PBYI:US $ -20.14M 15.04M
Takeda 4502:JP Y 61447M 161531M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M
Xencor XNCR:US $ -40.19M 92.44M